Walmart Plans to Reach 80+ HIV-Focused Specialty Pharmacies by Year End

Photo courtesy of Walmart

Earlier this month, Walmart opened 70 HIV-focused Specialty Pharmacies of the Community (SPOC) in locations across the country and the retailer plans to bring the total to over 80 locations in 11 states.

Walmart also said it plans to expand its focus in 2024 to include other autoimmune conditions such as skin, joint and gastrointestinal conditions.SPOC pharmacies are staffed by Walmart’s team of HIV-trained pharmacists, technicians and Community Health Workers, who are dedicated to removing barriers to care. The locations aim to help the retailer gain a greater understanding of the needs of people living with HIV as well as offer services tailored to their specialized needs.

Each SPOC is located discretely within a Walmart pharmacy and offers services including discussing treatment options, conversations around mental health, sharing resources and helping navigate insurance options. Walmart sees about 150 million customers each week, giving the retailer an opportunity to reach people who might not otherwise have access to or feel comfortable seeking HIV care through its SPOCs.

“Our pharmacists work with the patient’s prescribers to partner on a treatment plan that is best for them,” said Aleata Postell, Senior Director of Specialty Pharmacy Business Development at Walmart in a statement. “Our pharmacists are an integral part of a patient’s care team — and that’s exactly how our pharmacy teams are trained.”


Postell has a personal reason to improve HIV care and accessibility, as a family friend was diagnosed with HIV years before they revealed the diagnosis and began searching for treatment.

Featured Event

Join the retail community as we come together for three days of strategic sessions, meaningful off-site networking events and interactive learning experiences.



Access The Media Kit


Access Our Editorial Calendar

If you are downloading this on behalf of a client, please provide the company name and website information below: